Cargando…
Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?
OBJECTIVE: Estradiol (E2)-based hormonal contraceptives impact less than ethinylstradiol (EE) contraceptives on venous thromboembolism (VTE) in comparison to formulations with EE. STUDY DESIGN: In this article, the pharamacologic data of EE and E2 were briefly reviewed, along with the induced biolog...
Autores principales: | Fruzzetti, Franca, Cagnacci, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239102/ https://www.ncbi.nlm.nih.gov/pubmed/30519125 http://dx.doi.org/10.2147/OAJC.S179673 |
Ejemplares similares
-
COVID-19 and hormonal contraception
por: Cagnacci, Angelo, et al.
Publicado: (2022) -
The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011) -
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest
por: Fruzzetti, Franca, et al.
Publicado: (2012) -
Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019) -
The Role of Sex Hormones in the Disparity of COVID-19 Outcomes Based on Gender
por: Stasi, Vincenza Di, et al.
Publicado: (2021)